Viewing Study NCT00269867


Ignite Creation Date: 2025-12-25 @ 12:53 AM
Ignite Modification Date: 2026-02-20 @ 9:39 AM
Study NCT ID: NCT00269867
Status: COMPLETED
Last Update Posted: 2014-11-04
First Post: 2005-12-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Infliximab Plus Methotrexate for the Treatment of Rheumatoid Arthritis
Sponsor: Centocor, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module